SEC FORM 4
$2,383,028.38
BeOne Medicines Ltd. (ONC)
Sale of 6,717 shares at $354.7757 per share.
Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →